DBCO-PEG4 acetic-EVCit-PAB, with CAS number 2253947-17-8, is a pivotal chemical compound in the field of bioconjugation and drug delivery research. This compound is a derivative of dibenzocyclooctyne (DBCO), a highly reactive group known for its selective and efficient conjugation to azides or other strained alkenes, a process central to DBCO click chemistry. The structure of DBCO-PEG4 acetic-EVCit-PAB includes a PEG spacer with four ethylene glycol units, adding to its solubility and flexibility, and a maleimide group, coupled with a p-aminobenzoic acid group (PAB). These functional groups enable the compound to attach to proteins or peptides through the formation of stable thioether bonds.
This compound is immensely valuable for the development of targeted drug delivery systems or bioconjugates used in imaging, diagnosis, or therapeutic applications. Its versatility and efficiency make it a sought-after component in pharmaceutical research. For researchers and scientists looking to utilize DBCO in their work, understanding the nuances of DBCO NHS chemistry is also crucial. Moreover, for a comprehensive selection of DBCO-based compounds, including various DBCO linkers, AxisPharm provides a wide range of high-quality options that cater to different research requirements.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
